Literature DB >> 33667383

Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade.

Stefan Roth1, Jiayu Cao1, Vikramjeet Singh1, Steffen Tiedt2, Gabriel Hundeshagen3, Ting Li4, Julia D Boehme5, Dhruv Chauhan6, Jie Zhu1, Alessio Ricci1, Oliver Gorka7, Yaw Asare1, Jun Yang1, Mary S Lopez1, Markus Rehberg1, Dunja Bruder5, Shengxiang Zhang4, Olaf Groß8, Martin Dichgans2, Veit Hornung6, Arthur Liesz9.   

Abstract

Loss of lymphocytes, particularly T cell apoptosis, is a central pathological event after severe tissue injury that is associated with increased susceptibility for life-threatening infections. The precise immunological mechanisms leading to T cell death after acute injury are largely unknown. Here, we identified a monocyte-T cell interaction driving bystander cell death of T cells in ischemic stroke and burn injury. Specifically, we found that stroke induced a FasL-expressing monocyte population, which led to extrinsic T cell apoptosis. This phenomenon was driven by AIM2 inflammasome-dependent interleukin-1β (IL-1β) secretion after sensing cell-free DNA. Pharmacological inhibition of this pathway improved T cell survival and reduced post-stroke bacterial infections. As such, this study describes inflammasome-dependent monocyte activation as a previously unstudied cause of T cell death after injury and challenges the current paradigms of post-injury lymphopenia.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIM2; Fas; IL-1; T cell; burn; cell death; inflammasome; stroke; tissue injury

Year:  2021        PMID: 33667383     DOI: 10.1016/j.immuni.2021.02.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  12 in total

1.  Explaining post-injury T cell death.

Authors:  Lucy Bird
Journal:  Nat Rev Immunol       Date:  2021-04       Impact factor: 53.106

2.  Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage.

Authors:  Nuo Cheng; Hong Wang; Ming Zou; Wei-Na Jin; Fu-Dong Shi; Kaibin Shi
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-21       Impact factor: 6.960

Review 3.  Inflammatory Responses After Ischemic Stroke.

Authors:  Jonathan Howard DeLong; Sarah Naomi Ohashi; Kevin Charles O'Connor; Lauren Hachmann Sansing
Journal:  Semin Immunopathol       Date:  2022-06-29       Impact factor: 11.759

Review 4.  Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors.

Authors:  Gael Galli; Pierre Vacher; Bernhard Ryffel; Patrick Blanco; Patrick Legembre
Journal:  Cells       Date:  2022-04-24       Impact factor: 7.666

5.  Neutrophil Extracellular Traps Augmented Alveolar Macrophage Pyroptosis via AIM2 Inflammasome Activation in LPS-Induced ALI/ARDS.

Authors:  Haitao Li; Yi Li; Chao Song; Yongbin Hu; Minhui Dai; Ben Liu; Pinhua Pan
Journal:  J Inflamm Res       Date:  2021-09-21

Review 6.  Interleukins and Ischemic Stroke.

Authors:  Hua Zhu; Siping Hu; Yuntao Li; Yao Sun; Xiaoxing Xiong; Xinyao Hu; Junjing Chen; Sheng Qiu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

7.  A macrophage-T cell coculture model for severe tissue injury-induced T cell death.

Authors:  Jie Zhu; Jiayu Cao; Arthur Liesz; Stefan Roth
Journal:  STAR Protoc       Date:  2021-12-01

Review 8.  Why are bleeding trauma patients still dying? Towards a systems hypothesis of trauma.

Authors:  Geoffrey P Dobson; Jodie L Morris; Hayley L Letson
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

Review 9.  Immune dysfunction following severe trauma: A systems failure from the central nervous system to mitochondria.

Authors:  Geoffrey P Dobson; Jodie L Morris; Hayley L Letson
Journal:  Front Med (Lausanne)       Date:  2022-08-30

Review 10.  Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections.

Authors:  Júlia Faura; Alejandro Bustamante; Francesc Miró-Mur; Joan Montaner
Journal:  J Neuroinflammation       Date:  2021-06-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.